Pharmaceutical

Huadong enters licence deal for MC2 Therapeutics’ Wynzora cream

Huadong has entered into an agreement to acquire licence rights for MC2 Therapeutics’ Wynzora cream in Greater China.

Sep 1, 2023 - 20:00
Huadong enters licence deal for MC2 Therapeutics’ Wynzora cream
Huadong has entered into an agreement to acquire licence rights for MC2 Therapeutics’ Wynzora cream in Greater China.
Read the original article

Tags:

Previous Article

Reset Pharma partners with Filament to license psilocybin drug

Next Article

Otsuka Pharmaceutical agrees to buy Mindset Pharma

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Coherus undercuts AbbVie with discounted Humira; FDA approves second RSV vaccine

STAT+: Pharmalittle: Coherus undercuts AbbVie with disc...

Jun 2, 2023

Opinion: Medicare has different standards than the FDA. That’s how it should be

Opinion: Medicare has different standards than the FDA....

Feb 3, 2024

Dana-Farber expands studies to be retracted to 6, plus 31 to be corrected over mishandled data

Dana-Farber expands studies to be retracted to 6, plus ...

Jan 22, 2024